JFS Wealth Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17K Buy
37
+11
+42% +$461 ﹤0.01% 1582
2026
Q1
$838 Buy
26
+3
+13% +$111 ﹤0.01% 1696
2025
Q4
$969 Buy
23
+8
+53% +$322 ﹤0.01% 1709
2025
Q3
$515 Buy
15
+9
+150% +$258 ﹤0.01% 1758
2025
Q2
$163 Sell
6
-25
-81% -$724 ﹤0.01% 1788
2025
Q1
$920 Buy
31
+19
+158% +$724 ﹤0.01% 1664
2024
Q4
$476 Buy
12
+11
+1,100% +$416 ﹤0.01% 1785
2024
Q3
$35 Sell
1
-1
-50% -$28 ﹤0.01% 1943
2024
Q2
$44 Hold
2
﹤0.01% 1962
2024
Q1
$45 Buy
2
+1
+100% +$24 ﹤0.01% 1981
2023
Q4
$28 Sell
1
-5
-83% -$121 ﹤0.01% 1988
2023
Q3
$134 Hold
6
﹤0.01% 1891
2023
Q2
$153 Sell
6
-1
-14% -$24 ﹤0.01% 1899
2023
Q1
$157 Buy
+7
New +$169 ﹤0.01% 1851
2022
Q2
Sell
-6
Closed 1947
2022
Q1
$0 Buy
+6
New +$172 ﹤0.01% 1978

Other funds holding VCYT

JFS Wealth Advisors's VCYT Position: Q2 2026 in Review

JFS Wealth Advisors increased its Veracyte (VCYT) stake by 42% in Q2 2026, buying an estimated $461 and bringing the position to 37 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

JFS Wealth Advisors first reported a position in VCYT in Q1 2022 and has held it in 15 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • JFS Wealth Advisors held 37 shares of Veracyte worth $2.17K as of Q2 2026.
  • JFS Wealth Advisors bought 11 Veracyte shares in Q2 2026, an estimated $461.
  • Veracyte made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1582 holding.
  • JFS Wealth Advisors first reported a position in Veracyte in Q1 2022 and has held it in 15 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.